Old Web
English
Sign In
Acemap
>
authorDetail
>
Dariusz Woszczyk
Dariusz Woszczyk
Opole University
Internal medicine
Medicine
Oncology
Vincristine
Prednisone
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MOSUNETUZUMAB MONOTHERAPY IN ELDERLY/UNFIT PTS WITH FIRST-LINE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): SAFETY AND EFFICACY REMAIN PROMISING WITH DURABLE COMPLETE RESPONSES
2021
Hematological Oncology
Adam J. Olszewski
Abraham Avigdor
S. Babu
Itai Levi
Herbert Eradat
Uri Abadi
Houston Holmes
Matthew S. McKinney
Dariusz Woszczyk
Krzysztof Giannopoulos
Wojciech Jurczak
Ronald McCord
Yuying Xie
Kati Sarouei
Naseer Qayum
Carol OHear
Gila Sellam
Netanel A. Horowitz
Show All
Source
Cite
Save
Citations (0)
ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses
2021
Clinical Lymphoma, Myeloma & Leukemia
Adam J. Olszewski
Abraham Avigdor
Sunil Babu
Itai Levi
Herbert Eradat
Uri Abadi
Houston Holmes
Matthew S. McKinney
Dariusz Woszczyk
Krzysztof Giannopoulos
Wojciech Jurczak
Ron McCord
Yuying Xie
Mingzhu Zhou
Naseer Qayum
Carol OHear
Gila Sellam
Netanel A. Horowitz
Show All
Source
Cite
Save
Citations (0)
Pevonedistat (PEV) + Azacitidine (AZA) Versus AZA Alone As First-Line Treatment for Patients with Higher-Risk Myelodysplastic Syndromes (MDS)/Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) with 20–30% Marrow Blasts: The Randomized Phase 3 PANTHER Trial (NCT03268954)
2021
Blood
Mikkael A Sekeres
Larisa Girshova
Vadim A. Doronin
María Díez-Campelo
David Valcárcel
Suman Kambhampati
Nora-Athina Viniou
Dariusz Woszczyk
Raquel de Paz Arias
Argiris Symeonidis
Achilles Anagnostopoulos
Eduardo Cilião Munhoz
Uwe Platzbecker
Valeria Santini
Robert J. Fram
Ying Yuan
Douglas V. Faller
Lionel Ades
Show All
Source
Cite
Save
Citations (0)
1